🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate if a 12-week total regimen of tela...
Status
Terminated
Location
Multiple Locations
Start Date
2011-11
Trial ID
NCT01459913
Treatments Being Tested
The purpose of this study is to determine the safety, efficacy and tolerabi...
Status
Completed
Location
Multiple Locations
Start Date
2008-10
Trial ID
NCT00703118
Treatments Being Tested
The purpose of this study is to evaluate the effectiveness of telaprevir in...
Status
Completed
Location
Multiple Locations
Start Date
2012-02
Trial ID
NCT01571583
Treatments Being Tested
To examine the safety and efficacy of response guided triple therapy (PEG-I...
Status
Completed
Location
St Vincent's Hospital
Start Date
2013-01
Trial ID
NCT01743521
Treatments Being Tested
To assess efficacy of telaprevir, pegylated interferon alfa-2a (Peg-IFN-alf...
Status
Terminated
Location
Alabama
Start Date
2012-02
Trial ID
NCT01467505
Treatments Being Tested
To provide access to a telaprevir-based treatment to subjects of the Contro...
Status
Completed
Location
Multiple Locations
Start Date
2007-10
Trial ID
NCT00535847
Treatments Being Tested
The purpose of this study is to determine the effectiveness, safety and tol...
Status
Completed
Location
Multiple Locations
Start Date
2012-01
Trial ID
NCT01498068
Treatments Being Tested
The purpose of this study is to assess the safety and efficacy of combinati...
Status
Terminated
Location
Multiple Locations
Start Date
2010-08
Trial ID
NCT01080222
Treatments Being Tested
Patients are being asked to be part of this study because they are a liver ...
Status
Terminated
Location
University of Chicago Medical Center
Start Date
2012-04
Trial ID
NCT01592006
Treatments Being Tested
A Phase 3 study to evaluate the efficacy and safety of two dosing regimens ...
Status
Completed
Location
Multiple Locations
Start Date
2008-03
Trial ID
NCT00627926
Treatments Being Tested